The Vaccine and Infectious Disease Organization (VIDO) is Canada’s Centre for Pandemic Research. Located at the University of Saskatchewan in Saskatoon, Canada, VIDO is a leader in human and animal infectious disease research and vaccine development. For over 45 years we have developed solutions to emerging diseases including eight commercially available vaccines—six of which were world’s firsts, with four more in regulatory development.
As a National Centre, we are home to one of the largest and most advanced level 3 containment facilities capable of housing both small and large animals including rodents, poultry, pigs, cattle, and bison. We are currently expanding our specialized infrastructure to include a vaccine GMP manufacturing facility, a new multi-species level 2 animal facility, and upgraded capacity to include level 4 containment. Our vision includes the capacity to study any emerging disease in any animal model embracing a One Health approach to prevent emerging and re-emerging infectious disease of importance in human and veterinary health.
Drs. Angela Rasmussen and Arinjay Banerjee are seeking an outstanding Postdoctoral Fellow interested in studying SARS-CoV-2 host responses and species range at VIDO as part of a larger collaboration with the Coronavirus Variants Rapid Response Network (CoVaRR-Net). CoVaRR-Net is a CIHR-funded national network of scientists investigating SARS-CoV-2 variants of concern.
Host responses to viral infection are major determinants of disease susceptibility and severity, including for SARS-CoV-2. The Host-Pathogen Interactions Pillar (Pillar 2) of CoVaRR-Net was established to investigate the critical interactions between SARS-CoV-2 variants and different host species throughout Canada, with the goal of understanding the biology at the interface of host and pathogen, as well as assessing risks of zoonotic and zooanthroponotic transmission which may threaten humans, livestock, and wildlife in Canada.
We are seeking curious, motivated scientists who have recently completed their doctoral (PhD) studies with experience in virology to both conduct emerging virus research in our high containment laboratory, studying SARS-CoV-2 variants of concern at VIDO. This position will be jointly supervised by both Dr. Angela Rasmussen (Pillar 2 Lead) and Dr. Arinjay Banerjee (Pillar 2 Deputy). In addition, this post-doctoral fellow will have the opportunity to collaborate with the large, interdisciplinary team of scientists who are part of CoVaRR-Net Pillar 2, as well as the larger network.
The successful candidate must have recently completed (within 3 years) a PhD or equivalent with a background in microbiology and be willing to work in a Biosafety Level 3 laboratory. The ideal candidate will have experience in cell culture and molecular virology techniques. Prior experience with SARS-CoV-2 and work in CL-3 containment is preferred. Must be organized and a team player with strong oral and written communication skills, as projects will involve regular interactions with colleagues and collaborators. The candidate must be willing to comply with the University of Saskatchewan’s COVID-19 policies and vaccine requirements.
Status: 2-year term, with the possibility of extension
Employment Group: Post-Doctoral Fellows – PSAC
Full Time Equivalent (FTE): 1.0
Salary Information: The starting salary will follow the university standard for a post-doctoral researcher and will be commensurate with experience.
The successful applicant will be required to provide the following current verification(s) where 'Yes' is indicated below. Further information is available at: https://careers.usask.ca/tips-for-applying.php#Howtoapplyforaposition
Facility Access Screening including Criminal Record Check: Yes
Driver's License and Abstract Check: Not Applicable
Education/Credential Verification: Yes
Vulnerable Sector Check: Not Applicable
Interested candidates are asked to submit their application as a single PDF document including a cover letter, curriculum vitae, and contact information for three references.
The University of Saskatchewan has instated a number of health and safety requirements for faculty, staff and students in consideration of the COVID-19 pandemic. As of January 4, 2022, being fully vaccinated against COVID-19 is a condition of employment and proof of vaccination will be required. The University will consider accommodations requests for individuals in accordance with the requirements of the The Saskatchewan Human Rights Code, 2018.
Review of applications will begin immediately; however, applications will be accepted and evaluated until the position is filled. We thank all applicants for their interest; only those candidates selected for an interview will be contacted.
For more information visit: vido.org
Note: The University believes equity, diversity, and inclusion strengthen the community and enhance excellence, innovation and creativity. We are dedicated to recruiting individuals who will enrich our work and learning environments. All qualified candidates are encouraged to apply; however, in accordance with Canadian immigration requirements, Canadian citizens and permanent residents will be given priority. We are committed to providing accommodations to those with a disability or medical necessity. If you require an accommodation in order to participate in the recruitment process, please notify us and we will work together on the accommodation request. The University of Saskatchewan’s main campus is situated on Treaty 6 Territory and the Homeland of the Métis. We pay our respects to the First Nations and Métis ancestors of this place and reaffirm our relationship with one another. Together, we are uplifting Indigenization to a place of prominence at the University of Saskatchewan.